Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems.

Steve Knight, Sales & Marketing Director at Porvair Sciences commented "We have seen US demand for affordable 96-well and 384-well microplate sample concentration systems grow considerably over the last few years.  To enhance local informed support to this rapidly growing community of US customers we have turned to our well established US distribution partner - SPEware Corporation". He added "SPEware Corporation brings over 20-years’ experience of sample...

Agreement brings together expertise to design, develop and market small molecule libraries targeting ubiquitin system proteins.

Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and the Drug Discovery Unit (the DDU) of the University of Dundee, announced today they have entered into a collaboration agreement to develop and market new ubiquitin system targeted compound libraries aimed at discovering potent and selective therapeutics across multiple areas including; cancer, cardiovascular and metabolic...

Lyonbiopole announces that the French Health authority (ANSM) delivered to Accinov, its Innovation Centre, the authorization to open a pharmaceutical site.

This authorization will allow Accinov to support the companies hosted in the Centre for the production of biological drugs for clinical trials in particular with the pharmaceutical responsibility of Accinov. On September 11^th, the French Health authority (ANSM) delivered to Accinov the authorization to open a pharmaceutical site in its facilities located in Lyon-Gerland Biodistrict. This authorization followed an application submitted by Accinov to the...

Cherwell Secures UK Distribution Agreement with Mar Cor for Cleanroom Decontamination Products.

The importance of efficient, reliable decontamination of cleanrooms and other critical areas within the healthcare, pharmaceutical and biotech industries is undeniable. Having signed a UK distribution agreement with Mar Cor Purification, Cherwell Laboratories can now offer a range of dry fog technology and cold sterilant products to...

Agreement covers development of molecular reference standards for companion diagnostics.

Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announces that its business unit Horizon Diagnostics has signed a Master Services Agreement with a major global diagnostic development company and a US biopharmaceutical company to support the development of companion diagnostics for novel, genetically-targeted...

Cepheid’s GeneXpert^® Infinity System lies at the heart of an innovative, award-winning sexual health screening service in Soho, London. Dean Street Express – run by the Chelsea and Westminster Hospital NHS Foundation Trust – was recently declared the winner of the prestigious Health Service Journal ‘Value in Healthcare Award.

The recently launched CellSep Advanced kit, for use in combination with the Arrow™ Instrument for the automated isolation of up to three cell types directly from whole blood or buffy coat¹, was among the new developments revealed to distributors at the Annual DiaSorin Molecular Distributor Meeting held in Bandol, South of France. 

As demand for more automated methods for molecular diagnostics and research increases, DiaSorin aims to ensure that its distributors are equipped to meet the evolving needs of customers. The distributors received a range of support materials to help inform and train scientists interested in using CellSep Advanced, including animated films on the use of the Arrow™ Instrument, product literature, and an Application Note from the...

Lab Innovations, the UK’s only show dedicated to the latest laboratory technology and consumables, analytics and biotech equipment, returns to the Birmingham NEC on 5 & 6 November 2014.

ATCC increases focus on scientific reproducibility and leverages technological advances with new senior executive appointments

ATCC, the premier global biological materials resource and standards organization, is pleased to announce two important appointments to the senior leadership team. Barbie Bigelow has joined ATCC as Executive Vice President of Strategy and Technology and Dr. Maryellen de Mars also joins as the Senior Director for the Standards Resource Center. Both roles are new positions at ATCC.   Dr. Raymond H. Cypess, President and CEO at...

greenovation Biotech GmbH and BIOMEVA GmbH announced today the successful production of the world's first GMP (Good Manufacturing Practice)-compliant batch of drug substance manufactured in moss for clinical use.

The drug substance, greenovation's pilot candidate Moss-aGal (recombinant human alpha-galactosidase), is planned to be used for clinical testing as a new generation of enzyme replacement therapy in patients with Fabry disease in the near term. Based on broad experience in the production of proteins for preclinical testing, this production technology has been raised to the next level of successful GMP-manufacturing. The manufacturing of...

GENALICE and Knome, Inc. jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and analysis of their Next-Generation Sequencing (NGS) data.

GENALICE MAP is an ultra-fast and highly accurate NGS data preprocessing solution and will be connected to Knome’s informatics and genomics interpretation system, the knoSYS® platform. “In the era of high volume NGS data production, a streamlined and affordable pipeline for data processing and analysis is key,” explains Gabor Matyas from the Foundation. “The combination of the solutions of GENALICE and Knome allows our work to...

Horizon Discovery Group plc has agreed to acquire Sage Labs Inc. for up to $16M (£9.8M) in cash and up to $32M (£19.6M) through the issue of new ordinary shares.

The acquisition of Sage, a world leader in the generation of advanced in vivo transgenic disease models for use in preclinical research, builds upon the acquisition of CombinatoRx in July and makes Horizon the world’s leading gene-editing company and the go-to company for the provision of integrated product, service and research solutions at all stages of translational genomics and personalized medicine research from sequence to treatment...

Use of Picsara will provide a more streamlined and secure approach to the patient journey.

HCA International, providers of world class private hospital care, are to collaborate with Swedish-based medical imaging specialists Mawell to transform the delivery of frontline care, enhance their service to patients and improve clinical safety and security. Launching across all HCA International’s clinical UK sites early next year Picsara, a unique multidisciplinary imaging software solution, will enable medical staff across various specialities to capture, store, distribute, analyse, annotate and measure all non-radiology medical images and videos efficiently and securely to help...

Thanks to a novel software upgrade from Olympus, an optical resolution of up to 120 nm is now achieved in cell and tissue imaging.

With the new Olympus FV-OSR software, the FluoView FV1200 is transformed into a powerful system for confocal Super Resolution microscopy. Introducing a smart route to Super Resolution microscopy, the Olympus FV-OSR software module enables users of the FluoView FV1200 easy access to what was previously the domain of only specialised microscopy systems. The extra detail offered by Super Resolution technology facilitates researchers in...

Malvern Instruments will demonstrate how the Kinexus rotational rheometer and Mastersizer 3000 laser diffraction particle sizing system enable smarter, faster and more effective strategies for food development at FoodTech Processing & Packaging.

The conference takes place at MCH Messecenter Herning, Denmark, from 28 to 30 October 2014. Malvern’s food characterization experts will be on hand throughout the event to demonstrate the analytical strategies that help R&D and QC scientists develop high performance products with enhanced consumer appeal. Visit Malvern on stand M9912....

Sinensis Life Sciences B.V. has acquired Spinnovation Holding B.V. a contract research organisation specialised in the application of nuclear magnetic resonance (NMR) techniques in the pharmaceutical and biotechnological market.

Financial terms of the transaction were not disclosed. The addition of Spinnovation expands and strengthens Sinensis’ chemical R&D group as in addition to NMR Spinnovation offers mass spectrometry (MS) and inductively coupled plasma (ICP) spectroscopy analyses to its customers. Dr Ruud Santing, CEO of Sinensis, commented: “We are excited to add Spinnovation’s analytical equipment and many years of expertise to our existing...

The Clinical and Laboratory Standards Institute (CLSI) has published an updated standard—Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline—Third Edition (EP05-A3).

This document provides guidance for studies intended to establish the within-site precision performance characteristics of quantitative measurement procedures used in clinical laboratories, and also for studies addressing site-to-site variability. In CLSI document EP05-A3, multiple experimental protocols are described, along with considerations on how to select and optimize the protocol(s) best suited for a specific measurement...

The world-renowned GPCR specialist will assemble a team of experts in drug discovery and development to guide Domain’s programs.

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new medicines targeting G protein-coupled receptors (GPCRs), today announces the nomination of Michel Bouvier as chairman of the company’s Scientific Advisory Board. Michel Bouvier, PhD, is a professor in the Department of Biochemistry and Molecular Medicine at the University of Montreal and also chief executive officer of the Institute for...

Xylem will be exhibiting its analytical offering at LabInnovations, showcasing the products of Bellingham + Stanley, ebro, SI Analytics, O.I.Analytical and YSI Life Sciences.

The Pirbright Institute hosted its Centenary Conference at The University of Surrey  to mark its 100^th anniversary of the prevention and control of livestock infectious diseases and discuss current research into virus diseases of livestock and viruses that spread from animals to humans.

The event showcased the importance, challenges and progress in the control of livestock diseases and zoonoses and gave delegates the opportunity to interact and debate recent advances in the control, epidemiology, virology, immunology and vaccinology of viral diseases of livestock, including poultry, and viral zoonoses.  Delegates were also provided with a unique opportunity to tour the Institute’s new state-of the-art high biocontainment laboratory facility, the...

IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that University of Iowa and IBA have signed a research collaboration agreement and a technology license agreement to develop ultra-high precision IMPT(*).

This agreement includes an exclusive license on the Dynamic Collimation System (DCS) recently developed and presented by the University of Iowa at the American Association of Physicists in Medicine (AAPM) meeting in Austin, Texas. The Dynamic Collimation System is an innovative device developed by University of Iowa Carver College of Medicine faculty members(**) to improve dose conformity in IMPT...

Company Wins ISO and EN Certification for its Design & Development Capabilities

Medtech innovator Medimetrics continues its expansion into the global medical devices sector with official recognition of its full design and product development capabilities and the launch of a new, fast release, drug delivery capsule. Medimetrics has newly achieved a certification of compliance to EN ISO 13485:2012.  This enhanced level of certification further confirms the company’s expertise in the design, development, manufacturing and...